“…Gupta et al, 8 reported similar findings, showing Black men received fewer UI corrective procedures compared to White men (2.1% vs 4.3%, p = 0.001). In another study, McAbee et al 9 reported that an overwhelmingly higher proportion of AUS and male sling insertions recorded within a single‐surgeon's database were performed on White men (9% vs. 87.2%, p = 0.018). While the racial disparities in receipt of ED and UI surgical care are puzzling, they remain substantial and have been observed outside the context of PCa diagnosis.…”
Section: Discussionmentioning
confidence: 99%
“…Similarly, the cost of the surgical treatment options for UI has a potential to perpetuate existing racial and socioeconomic disparities in receipt and time to initiation of therapy. 7 However, while a few previous studies have reported the impact of race, 8 , 9 no study has investigated both disparity trends in men with post‐PCa treatment UI. We hypothesized that Black men and men of lower income groups would be less likely to receive ED and UI surgical care compared to White men and those of higher income groups.…”
ObjectivesTo investigate the racial and socioeconomic (income) differences in receipt of and time to surgical care for urinary incontinence (UI) and erectile dysfunction (ED) occurring post‐radical prostatectomy (RP) and/or radiation therapy (RT).Materials and MethodsUtilizing the Medicare Standard Analytical Files (SAF), a retrospective cohort study was performed on data of patients diagnosed with prostate cancer (PCa) from 2015 to 2021. Patients who underwent RP and/or RT and who subsequently developed UI and/or ED were grouped into four cohorts: RP‐ED, RP‐UI, RT‐ED and RT‐UI. County‐level median household income was cross‐referenced with SAF county codes, classified into income quartiles, and used as a proxy for patient income status. The rate of surgical care was compared between groups using two‐sample t‐test and log‐rank test. Cox proportional hazards modelling was used to determine covariate‐adjusted impact of race on time to surgical care.ResultsThe rate of surgical care was 6.8, 3.61 3.07, and 1.54 per 100 person‐years for the RP‐UI, RT‐UI, RP‐ED, and RT‐ED cohorts, respectively. Cox proportional ‘time‐to‐surgical care’ regression analysis revealed that Black men were statistically more likely to receive ED surgical care (RP‐ED AHR:1.79, 95% CI:1.49–2.17; RT‐ED AHR:1.50, 95% CI:1.11–2.01), but less likely to receive UI surgical care (RP‐UI AHR:0.80, 95% CI:0.67–0.96) than White men, in all cohorts except RT‐UI. Surgical care was highest among Q1 (lowest income quartile) patients in all cohorts except RT‐UI.ConclusionsSurgical care for post‐PCa treatment complications is low, and significantly impacted by racial and socioeconomic (income) differences. Prospective studies investigating the basis of these results would be insightful.
“…Gupta et al, 8 reported similar findings, showing Black men received fewer UI corrective procedures compared to White men (2.1% vs 4.3%, p = 0.001). In another study, McAbee et al 9 reported that an overwhelmingly higher proportion of AUS and male sling insertions recorded within a single‐surgeon's database were performed on White men (9% vs. 87.2%, p = 0.018). While the racial disparities in receipt of ED and UI surgical care are puzzling, they remain substantial and have been observed outside the context of PCa diagnosis.…”
Section: Discussionmentioning
confidence: 99%
“…Similarly, the cost of the surgical treatment options for UI has a potential to perpetuate existing racial and socioeconomic disparities in receipt and time to initiation of therapy. 7 However, while a few previous studies have reported the impact of race, 8 , 9 no study has investigated both disparity trends in men with post‐PCa treatment UI. We hypothesized that Black men and men of lower income groups would be less likely to receive ED and UI surgical care compared to White men and those of higher income groups.…”
ObjectivesTo investigate the racial and socioeconomic (income) differences in receipt of and time to surgical care for urinary incontinence (UI) and erectile dysfunction (ED) occurring post‐radical prostatectomy (RP) and/or radiation therapy (RT).Materials and MethodsUtilizing the Medicare Standard Analytical Files (SAF), a retrospective cohort study was performed on data of patients diagnosed with prostate cancer (PCa) from 2015 to 2021. Patients who underwent RP and/or RT and who subsequently developed UI and/or ED were grouped into four cohorts: RP‐ED, RP‐UI, RT‐ED and RT‐UI. County‐level median household income was cross‐referenced with SAF county codes, classified into income quartiles, and used as a proxy for patient income status. The rate of surgical care was compared between groups using two‐sample t‐test and log‐rank test. Cox proportional hazards modelling was used to determine covariate‐adjusted impact of race on time to surgical care.ResultsThe rate of surgical care was 6.8, 3.61 3.07, and 1.54 per 100 person‐years for the RP‐UI, RT‐UI, RP‐ED, and RT‐ED cohorts, respectively. Cox proportional ‘time‐to‐surgical care’ regression analysis revealed that Black men were statistically more likely to receive ED surgical care (RP‐ED AHR:1.79, 95% CI:1.49–2.17; RT‐ED AHR:1.50, 95% CI:1.11–2.01), but less likely to receive UI surgical care (RP‐UI AHR:0.80, 95% CI:0.67–0.96) than White men, in all cohorts except RT‐UI. Surgical care was highest among Q1 (lowest income quartile) patients in all cohorts except RT‐UI.ConclusionsSurgical care for post‐PCa treatment complications is low, and significantly impacted by racial and socioeconomic (income) differences. Prospective studies investigating the basis of these results would be insightful.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.